Direct effects of bisphosphonates on breast cancer cells

Breast Cancer Research

Volumn 4, Issue 1, 2002, Pages 18-23

  Senaratne, Siddhika G ^a   Colston, Kay W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Bisphosphonates; Breast cancer; Cell adhesion; Invasion

Indexed keywords

ALENDRONIC ACID; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BISPHOSPHONIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CASPASE 3; CASPASE INHIBITOR; CLODRONIC ACID; DOCETAXEL; EB 1053; GELATINASE A; GELATINASE B; IBANDRONIC ACID; NE 10244; NE 10790; NE 58051; PACLITAXEL; PAMIDRONIC ACID; PYRIDINIUM DERIVATIVE; RISEDRONIC ACID; TAXOID; UNCLASSIFIED DRUG; ZINC; ZOLEDRONIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BONE MATRIX; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOLYSIS; REVIEW;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; DIPHOSPHONATES; FEMALE; HUMANS; TUMOR CELLS, CULTURED;

EID: 0036148499     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr412     Document Type: Review

References (32)

1. Osteolytic metastases in breast carcinoma. Pathogenesis, morbidity and bisphosphonates treatment
2. Bone metastases in breast cancer, prostate cancer and myeloma
3. The clinical course of bone metastases from breast cancer
4. Mechanism of osteolytic bone destruction
5. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: Long term follow-up of two randomized, placebo-control trials
6. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix
7. Intravenous etidronate in the management of malignant hypercalcaemia
8. Effects of intravenous etidronate on skeletal and calcium metabolism
9. Migration and phenotypic transformation of osteoclasts precursors into mature osteoclasts: The effect of a bisphosphonate
10. Inhibition of osteoclast-like cell formation by bisphosphonates in long term cultures of human bone marrow
11. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
12. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages
13. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice
14. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonates ibandronate and tissue inhibitor of the matrix metalloproteinase-2
15. Alendronate acts on bone resorption of human osteoclast-like cells through the inhibition of cell attachment to bone surfaces
16. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro
17. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices
18. Additive antitumour activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone
19. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases
20. Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumour
21. Bisphosphonate induced apoptosis of human myeloma cell lines: A novel antitumour activity
22. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
23. Bisphosphonates induce apoptosis in human breast cancer cell lines
24. Influence of clodronate on breast cancer cells in vitro
25. Bisphosphonates induce breast cancer cell death in vitro
26. Mechanisms involved in aminobisphosphonate-induced apoptosis in breast cancer cells
27. The bisphosphonate lbandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases
28. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: Evidence for synergy with paclitaxel
29. Heterocycle-containing bisphosphonates causes apoptosis and inhibit bone resorption by preventing protein prenylation: Evidence from structure-activity relationships in J774 macrophages
30. The bisphosphonates incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway
31. Bisphosphonates action. Alendronate localization in rat bone and effects on osteoclast ultrastructure